Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813 Article

Chang, Susan, Zhang, Peixin, Cairncross, J Gregory et al. (2017). Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813 . NEURO-ONCOLOGY, 19(2), 252-258. 10.1093/neuonc/now236

Open Access International Collaboration

cited authors

  • Chang, Susan; Zhang, Peixin; Cairncross, J Gregory; Gilbert, Mark R; Bahary, Jean-Paul; Dolinskas, Carol A; Chakravarti, Arnab; Aldape, Kenneth D; Bell, Erica H; Schiff, David; Jaeckle, Kurt; Brown, Paul D; Barger, Geoffrey R; Werner-Wasik, Maria; Shih, Helen; Brachman, David; Penas-Prado, Marta; Robins, H Ian; Belanger, Karl; Schultz, Christopher; Hunter, Grant; Mehta, Minesh

sustainable development goals

authors

publication date

  • February 1, 2017

published in

keywords

  • CHEMOTHERAPY
  • Clinical Neurology
  • LOMUSTINE
  • Life Sciences & Biomedicine
  • MUTATIONS
  • Neurosciences & Neurology
  • Oncology
  • PROCARBAZINE
  • Science & Technology
  • TRIAL
  • VINCRISTINE
  • anaplastic astrocytoma
  • nitrosourea
  • radiotherapy
  • temozolomide

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 252

end page

  • 258

volume

  • 19

issue

  • 2